Glenmark Pharmaceuticals Limited (GLENMARK.NS)
INR 1541.1
(1.08%)
INR 1541.1
(1.08%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 143.58 Billion INR | -25.88% |
| 2022 | 193.71 Billion INR | 13.4% |
| 2021 | 170.83 Billion INR | 9.48% |
| 2020 | 156.03 Billion INR | 6.26% |
| 2019 | 146.84 Billion INR | 7.35% |
| 2018 | 136.78 Billion INR | 5.05% |
| 2017 | 130.2 Billion INR | 6.62% |
| 2016 | 122.11 Billion INR | 9.99% |
| 2015 | 111.02 Billion INR | 14.61% |
| 2014 | 96.87 Billion INR | 12.21% |
| 2013 | 86.33 Billion INR | 20.4% |
| 2012 | 71.71 Billion INR | 21.88% |
| 2011 | 58.83 Billion INR | 15.41% |
| 2010 | 50.97 Billion INR | 4.38% |
| 2009 | 48.83 Billion INR | 14.71% |
| 2008 | 42.57 Billion INR | 44.54% |
| 2007 | 29.45 Billion INR | 51.53% |
| 2006 | 19.43 Billion INR | 43.86% |
| 2005 | 13.51 Billion INR | 47.31% |
| 2004 | 9.17 Billion INR | 101.27% |
| 2003 | 4.55 Billion INR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 FY | 143.58 Billion INR | -25.88% |
| 2023 Q2 | 200.06 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q4 | 143.58 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 180.3 Billion INR | 0.0% |
| 2022 Q4 | 193.71 Billion INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 FY | 193.71 Billion INR | 13.4% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q4 | 170.83 Billion INR | 0.0% |
| 2021 Q2 | 166.13 Billion INR | 0.0% |
| 2021 FY | 170.83 Billion INR | 9.48% |
| 2020 Q3 | - INR | -100.0% |
| 2020 FY | 156.03 Billion INR | 6.26% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q2 | 150.91 Billion INR | 0.0% |
| 2020 Q4 | 156.03 Billion INR | 0.0% |
| 2019 FY | 146.84 Billion INR | 7.35% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q4 | 146.84 Billion INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q2 | 138.35 Billion INR | 0.0% |
| 2018 FY | 136.78 Billion INR | 5.05% |
| 2018 Q4 | 132.95 Billion INR | 0.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 Q2 | 140.38 Billion INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2017 Q3 | - INR | -100.0% |
| 2017 FY | 130.2 Billion INR | 6.62% |
| 2017 Q4 | 130.2 Billion INR | 0.0% |
| 2017 Q2 | 130.11 Billion INR | 0.0% |
| 2017 Q1 | - INR | -100.0% |
| 2016 FY | 122.11 Billion INR | 9.99% |
| 2016 Q1 | - INR | -100.0% |
| 2016 Q2 | 132.34 Billion INR | 0.0% |
| 2016 Q3 | - INR | -100.0% |
| 2016 Q4 | 122.11 Billion INR | 0.0% |
| 2015 FY | 111.02 Billion INR | 14.61% |
| 2015 Q3 | - INR | -100.0% |
| 2015 Q1 | - INR | -100.0% |
| 2015 Q4 | 108.35 Billion INR | 0.0% |
| 2015 Q2 | 104.51 Billion INR | 0.0% |
| 2014 Q2 | 85.45 Billion INR | 0.0% |
| 2014 Q4 | 96.87 Billion INR | 0.0% |
| 2014 Q3 | - INR | -100.0% |
| 2014 Q1 | - INR | -100.0% |
| 2014 FY | 96.87 Billion INR | 12.21% |
| 2013 FY | 86.33 Billion INR | 20.4% |
| 2013 Q4 | 86.33 Billion INR | 0.0% |
| 2013 Q1 | - INR | -100.0% |
| 2013 Q3 | - INR | -100.0% |
| 2013 Q2 | 81.04 Billion INR | 0.0% |
| 2012 FY | 71.71 Billion INR | 21.88% |
| 2012 Q4 | 71.71 Billion INR | 0.0% |
| 2012 Q2 | 60.77 Billion INR | 0.0% |
| 2012 Q3 | - INR | -100.0% |
| 2011 Q4 | 58.83 Billion INR | 0.0% |
| 2011 FY | 58.83 Billion INR | 15.41% |
| 2010 FY | 50.97 Billion INR | 4.38% |
| 2009 FY | 48.83 Billion INR | 14.71% |
| 2008 FY | 42.57 Billion INR | 44.54% |
| 2007 FY | 29.45 Billion INR | 51.53% |
| 2006 FY | 19.43 Billion INR | 43.86% |
| 2005 FY | 13.51 Billion INR | 47.31% |
| 2004 FY | 9.17 Billion INR | 101.27% |
| 2003 FY | 4.55 Billion INR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Sigachi Industries Limited | 6.94 Billion INR | -1968.5% |
| Ind-Swift Limited | 6.54 Billion INR | -2093.927% |
| Bajaj HealthCare Limited | 7.65 Billion INR | -1776.631% |
| Sakar Healthcare Limited | 3.88 Billion INR | -3594.401% |
| Aurobindo Pharma Limited | 450.71 Billion INR | 68.143% |
| Innova Captab Limited | 13.2 Billion INR | -987.049% |
| Divi's Laboratories Limited | 154.7 Billion INR | 7.184% |
| AstraZeneca Pharma India Limited | 10.78 Billion INR | -1231.934% |
| Morepen Laboratories Limited | 12.93 Billion INR | -1010.313% |
| Mankind Pharma Limited | 119.63 Billion INR | -20.023% |
| Sequent Scientific Limited | 15.4 Billion INR | -832.146% |
| Wanbury Limited | 3.43 Billion INR | -4080.178% |
| Laurus Labs Limited | 83.87 Billion INR | -71.2% |
| Nectar Lifesciences Limited | 21.91 Billion INR | -555.329% |
| Glenmark Life Sciences Limited | 28.5 Billion INR | -403.739% |
| Alembic Limited | 23.28 Billion INR | -516.575% |
| Hikal Limited | 24.87 Billion INR | -477.315% |
| Alembic Pharmaceuticals Limited | 64.45 Billion INR | -122.767% |
| Neuland Laboratories Limited | 18.32 Billion INR | -683.528% |
| J. B. Chemicals & Pharmaceuticals Limited | 39.94 Billion INR | -259.493% |
| IOL Chemicals and Pharmaceuticals Limited | 22.44 Billion INR | -539.753% |
| Themis Medicare Limited | 5.66 Billion INR | -2434.994% |
| RPG Life Sciences Limited | 5.12 Billion INR | -2699.662% |
| Zydus Lifesciences Limited | 292.8 Billion INR | 50.962% |
| Lupin Limited | 239.97 Billion INR | 40.165% |
| Amrutanjan Health Care Limited | 3.66 Billion INR | -3813.811% |
| Wockhardt Limited | 76.49 Billion INR | -87.719% |
| Vaishali Pharma Limited | 799.55 Million INR | -17858.224% |
| Aarti Pharmalabs Limited | 25.82 Billion INR | -456.083% |
| Jagsonpal Pharmaceuticals Limited | 2.17 Billion INR | -6514.5% |
| Jubilant Pharmova Limited | 115.48 Billion INR | -24.333% |
| FDC Limited | 24.68 Billion INR | -481.771% |
| Dr. Reddy's Laboratories Limited | 387.51 Billion INR | 62.947% |
| Kilitch Drugs (India) Limited | 2.4 Billion INR | -5881.225% |
| Eris Lifesciences Limited | 70.48 Billion INR | -103.702% |
| Venus Remedies Limited | 6.26 Billion INR | -2190.673% |
| ZIM Laboratories Limited | 4.46 Billion INR | -3113.498% |
| Bliss GVS Pharma Limited | 12.13 Billion INR | -1082.881% |
| Par Drugs and Chemicals Limited | 1.01 Billion INR | -14030.96% |
| Caplin Point Laboratories Limited | 26.97 Billion INR | -432.317% |
| Shilpa Medicare Limited | 30.93 Billion INR | -364.199% |
| Albert David Limited | 4.97 Billion INR | -2783.307% |
| Ajanta Pharma Limited | 46.38 Billion INR | -209.561% |
| Hester Biosciences Limited | 6.62 Billion INR | -2067.84% |
| Suven Pharmaceuticals Limited | 22.54 Billion INR | -537.004% |
| Solara Active Pharma Sciences Limited | 23.46 Billion INR | -511.891% |
| Gufic Biosciences Limited | 10.92 Billion INR | -1214.24% |
| Windlas Biotech Limited | 6.26 Billion INR | -2192.955% |
| Procter & Gamble Health Limited | 7.94 Billion INR | -1707.571% |
| Aarey Drugs & Pharmaceuticals Limited | 3.04 Billion INR | -4607.867% |
| Mangalam Drugs & Organics Limited | 3.33 Billion INR | -4206.413% |
| Granules India Limited | 55.2 Billion INR | -160.074% |
| Aarti Drugs Limited | 24.32 Billion INR | -490.317% |
| Bal Pharma Limited | 3.2 Billion INR | -4381.622% |
| Alkem Laboratories Limited | 155.74 Billion INR | 7.809% |
| Sun Pharmaceutical Industries Limited | 854.62 Billion INR | 83.199% |
| Lincoln Pharmaceuticals Limited | 7 Billion INR | -1950.381% |
| Medicamen Biotech Limited | 2.94 Billion INR | -4775.223% |
| Unichem Laboratories Limited | 31.69 Billion INR | -353.047% |
| Bafna Pharmaceuticals Limited | 1.47 Billion INR | -9622.69% |
| Biofil Chemicals and Pharmaceuticals Limited | 470.82 Million INR | -30396.603% |
| Valiant Laboratories Limited | 3.42 Billion INR | -4090.008% |
| Orchid Pharma Limited | 15.53 Billion INR | -824.053% |
| Medico Remedies Limited | 961.95 Million INR | -14826.534% |
| Ind-Swift Laboratories Limited | 11.65 Billion INR | -1132.387% |
| Ipca Laboratories Limited | 111.01 Billion INR | -29.342% |
| Brooks Laboratories Limited | 904.45 Million INR | -15775.461% |
| Syncom Formulations (India) Limited | 4.04 Billion INR | -3448.284% |
| Piramal Enterprises Limited | 826.05 Billion INR | 82.618% |
| Torrent Pharmaceuticals Limited | 150.61 Billion INR | 4.664% |
| NATCO Pharma Limited | 69.06 Billion INR | -107.906% |
| Suven Life Sciences Limited | 2.84 Billion INR | -4939.834% |
| Krebs Biochemicals & Industries Limited | 1.78 Billion INR | -7958.733% |
| Strides Pharma Science Limited | 58.39 Billion INR | -145.877% |
| Indoco Remedies Limited | 21.44 Billion INR | -569.484% |
| Alpa Laboratories Limited | 1.82 Billion INR | -7762.496% |
| Lasa Supergenerics Limited | 1.5 Billion INR | -9417.298% |
| Sun Pharma Advanced Research Company Limited | 5.15 Billion INR | -2687.866% |